PODD vs SER · P/E 34, rev $2.07B vs rev $56.0K
Insulet Corporation (PODD) versus Serina Therapeutics Inc (SER) — a side-by-side from cached financials, not a winner call.
Insulet Corporation (PODD) is a medical devices company listed on NASDAQ.
Serina Therapeutics Inc (SER) is a biotechnology company listed on AMEX.
Latest reported PODD revenue for 2024-12-31 was $2.07B. Net income was $418.3M. Revenue was up 22.1% from 2023-12-31 to 2024-12-31. PODD currently screens at market cap $9.94B and trailing P/E 33.5.
Latest reported SER revenue for 2024-12-31 was $56.0K. Net income was -$11.2M. Revenue was down 98.2% from 2023-12-31 to 2024-12-31. SER currently screens at market cap $29.7M.
PODD currently screens at market cap $9.94B and trailing P/E 33.5. SER currently screens at market cap $29.7M.
Not investment advice. Open the PODD and SER stock pages for the full models.
Not investment advice.